Clinical Trial

The Impact of Exercise on the Tumor Microenvironment in Patients With Lung Cancer

Recruiting
View on ClinicalTrials.gov →
Summary
There is increased interest and knowledge about the lung cancer tumor microenvironment (TME). Investigators hypothesize that patients with better baseline physiologic health will have better post-operative outcomes and that strenuous exercise will alter the TME and genetic make-up of the tumor, improving the tumor immune response. Investigators aim to identify the peri-operative and clinical outcomes that differ based on pre-operative VO2max, HRV and resting heart rate following resection of early-stage lung cancer. The physiologic states that are individual and measurable with wearable devices include but are not limited to VO2max, heart rate variability (HRV), and average resting heart rate. Investgators hypothesize that a patient's pre-operative physiologic function with higher VO2max, HRV and lower resting heart rate will be associated with improved peri-operative and post-operative outcomes. Second, investigators will compare alterations in TME based on targeted pre-operative exercise (60-80% of their VO2 max for 75min/week x2 weeks) compared to normal activity adults following resection of early-stage lung cancer. Investigators hypothesize that strenuous exercise in the pre-operative period will impact the TME by increasing levels of cytokines.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-10-08; most recent amendment 2026-04-16.
Status change: Not Yet Recruiting → Recruiting 2026-04-16
Trial Details
NCT Number NCT07216209
Lead Sponsor University of Arizona
Conditions Lung Cancer - Non Small Cell
Enrollment 48 participants
Start Date 2026-01-13
Primary Completion 2030-01-15 (estimated)
Study Completion 2030-01-15 (estimated)
Updated on ClinicalTrials.gov 2026-04-21